Publications by authors named "James Frane"

Claim this Profile
G
Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
Kamal N Bharucha, Hermine I Brunner, Inmaculada Calvo Penadés, Irina Nikishina, Nadina Rubio-Pérez, James Frane

J Rheumatol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial.
Fabrizio De Benedetti, Hermine Brunner, Nicolino Ruperto, Rayfel Schneider, Ricardo Xavier, James W Frane

Arthritis Rheumatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult and near-adult height in patients with severe insulin-like growth factor-I deficiency after long-term therapy with recombinant human insulin-like growth factor-I.
Philippe F Backeljauw, Joyce Kuntze, James Frane, Ali S Calikoglu, Steven D Chernausek

Horm Res Paediatr· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age of thelarche and menarche in contemporary US females: a cross-sectional analysis.
Susanne M Cabrera, George M Bright, James W Frane, Sandra L Blethen, Peter A Lee

J Pediatr Endocrinol Metab· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of children with the best and poorest first- and second-year growth during rhGH therapy: data from 25 years of the Genentech national cooperative growth study (NCGS).
Paul B Kaplowitz, Dorothy I Shulman, James W Frane, Joan Jacobs, Barbara Lippe

Int J Pediatr Endocrinol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A method to determine the likelihood of transition to puberty in a heterogeneous prepubertal age group.
James Frane, George M Bright, Peter A Lee

J Pediatr Endocrinol Metab· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there "seasonal" variation in height velocity in children treated with growth hormone? Data from the National Cooperative Growth Study.
Dorothy I Shulman, James Frane, Barbara Lippe

Int J Pediatr Endocrinol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study.
Richard Noto, Thomas Maneatis, James Frane, Kimberly Alexander, Barbara Lippe

J Pediatr Endocrinol Metab· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report.
John D Mahan, Bradley A Warady, James Frane, Ron G Rosenfeld, Rita D Swinford

Pediatr Nephrol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
L Kurt Midyett, Alan D Rogol, Quentin L Van Meter, James Frane, George M Bright

J Clin Endocrinol Metab· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A stepwise increase in recombinant human growth hormone dosing during puberty achieves improved pubertal growth: a National Cooperative Growth Study report.
Linda Riddick, Craig Alter, D Aaron Davis, James Frane, Barbara Lippe

J Pediatr Endocrinol Metab· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Wayne V Moore, Ken Dana, James Frane, Barbara Lippe

Pediatr Endocrinol Rev· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.
Bert Bakker, James Frane, Henry Anhalt, Barbara Lippe, Ron G Rosenfeld

J Clin Endocrinol Metab· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
Steven D Chernausek, Philippe F Backeljauw, James Frane, Joyce Kuntze, Louis E Underwood

J Clin Endocrinol Metab· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
Stephen F Kemp, Joyce Kuntze, Kenneth M Attie, Thomas Maneatis, S Butler, James Frane

J Clin Endocrinol Metab· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief review of the use and utility of growth hormone stimulation testing in the NCGS: do we need to do provocative GH testing?
Darrell M Wilson, James Frane

Growth Horm IGF Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis